Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × FED × Ureteral Neoplasms × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 3 Urinary Bladder Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Incontinence 1 Ureteral Neoplasms 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Health Education 1 Erectile Dysfunction 1 Colonic Polyps 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Atypical Squamous Cells of the Cervix 1

Interventions

copanlisib 1 avelumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05687721 2025-06-15

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

VA Office of Research and Development

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡